All In MedTech

FDA Clearance Tracker · P160054-S029

HeartMate 3 Left Ventricular Assist System (LVAS)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 10, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P160054-S029
Device name
HeartMate 3 Left Ventricular Assist System (LVAS)
Applicant location
Pleasanton, CA
Received
Apr 16, 2020
Decided
Jul 10, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P160054

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code DSQ

FDA's approval statement

As written in FDA's record.

Approval for a packaging design change and a supplier process change to the HeartMate 3 Coring Tool.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.